MCID: CMM005
MIFTS: 57

Common Cold

Categories: Infectious diseases, Oral diseases, Respiratory diseases, Smell/Taste diseases

Aliases & Classifications for Common Cold

MalaCards integrated aliases for Common Cold:

Name: Common Cold 12 75 55 43 3 44 15 17 72
Acute Viral Rhinopharyngitis 12
Nasopharyngitis - Acute 12
Nasopharyngitis, Acute 12
Acute Nasopharyngitis 12
Rhino-Sinusitis 12
Acute Rhinitis 12
Rhinosinusitis 15
Acute Coryza 12
Common Colds 63

Classifications:



External Ids:

Disease Ontology 12 DOID:10459
ICD9CM 35 460
MeSH 44 D003139
SNOMED-CT 68 54150009 82272006
ICD10 33 J00
UMLS 72 C0009443

Summaries for Common Cold

MedlinePlus : 43 Sneezing, sore throat, a stuffy nose, coughing - everyone knows the symptoms of the common cold. It is probably the most common illness. In the course of a year, people in the United States suffer 1 billion colds. You can get a cold by touching your eyes or nose after you touch surfaces with cold germs on them. You can also inhale the germs. Symptoms usually begin 2 or 3 days after infection and last 2 to 14 days. Washing your hands and staying away from people with colds will help you avoid colds. There is no cure for the common cold. But there are treatments that can make you feel better while you wait for the cold to go away on its own: Getting plenty of rest Drinking fluids Gargling with warm salt water Using cough drops or throat sprays Taking over-the-counter pain or cold medicines However, do not give aspirin to children. And do not give cough medicine to children under four.

MalaCards based summary : Common Cold, also known as acute viral rhinopharyngitis, is related to pulmonary disease, chronic obstructive and viral infectious disease, and has symptoms including fever, pruritus and tinnitus. An important gene associated with Common Cold is CCL11 (C-C Motif Chemokine Ligand 11), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Cefditoren and Capsaicin have been mentioned in the context of this disorder. Affiliated tissues include testes, eye and lung, and related phenotypes are hematopoietic system and digestive/alimentary

Disease Ontology : 12 An upper respiratory tract disease which involves inflammation of the mucous membranes of the nose, throat, eyes, and eustachian tubes with watery then purulent discharge. This is an acute contagious disease caused by rhinoviruses, human parainfluenza viruses, human respiratory syncytial virus, influenza viruses, adenoviruses, enteroviruses, or metapneumovirus.

CDC : 3 Sore throat and runny nose are usually the first signs of a cold, followed by coughing and sneezing. Most people recover in about 7-10 days. You can help reduce your risk of getting a cold: wash your hands often, avoid close contact with sick people, and don't touch your face with unwashed hands.

PubMed Health : 63 About common colds: Common colds, or simply “colds,” are usually quite harmless and go away again on their own. Symptoms of a cold such as a cough, sore throat and a runny nose can be really annoying. A severe cold can make you feel weak and ill, too. Colds usually go away on their own after about a week, but some symptoms may last longer. Although a sore throat or a stuffy nose may be gone after just a few days, it can sometimes take up to three weeks for a cough to disappear completely. Treatment with medication usually isn’t necessary. Some medications may, at best, help relieve the symptoms a bit. Because colds are typically caused by viruses, it also doesn't make sense to use antibiotics to treat an ordinary cold. Antibiotics only work against bacteria.

Wikipedia : 75 The common cold, also known simply as a cold, is a viral infectious disease of the upper respiratory... more...

Related Diseases for Common Cold

Diseases related to Common Cold via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 511)
# Related Disease Score Top Affiliating Genes
1 pulmonary disease, chronic obstructive 32.2 RNASE3 IL13 CXCL8 CCL5 CCL11
2 viral infectious disease 32.0 IFNA2 CXCL8 CCL5
3 otitis media 30.7 RNASE3 CXCL8 CCL11 ALB
4 cellulitis 30.4 RNASE3 IL5 IL1R1
5 pyoderma 30.2 IL1R1 IFNA2 CXCL8
6 bronchitis 30.2 RNASE3 IL5 CXCL8 CCL11 ALB
7 maxillary sinusitis 30.1 SELP RNASE3 CCL5
8 cytokine deficiency 30.1 IL5 IL13
9 uveitis 30.1 IL1R1 IFNA2 ICAM1
10 food allergy 29.9 RNASE3 IL5 IL13 ALB
11 bullous pemphigoid 29.8 RNASE3 IL5 CCL11
12 dermatitis 29.7 TSLP IL5 IL13 CCL11
13 status asthmaticus 29.6 RNASE3 IL5 CXCL8 CCL5
14 rhinitis 29.5 RNASE3 IL5 IL13 ICAM1 CXCL8 CCL5
15 hypereosinophilic syndrome 29.5 RNASE3 IL5 IL13 CCL11
16 ige responsiveness, atopic 29.4 RNASE3 IL5 IL13
17 allergic rhinitis 29.3 RNASE3 IL5 IL13 ICAM1 CXCL8 CCL11
18 pollen allergy 29.1 RNASE3 IL5 IL13 ICAM1
19 esophagitis, eosinophilic, 1 29.1 TSLP IL5 IL13 CCL11
20 pneumonia 29.1 IL5 IL13 CXCL8 CCL5 CCL11
21 myocardial infarction 29.0 SELP POSTN LDLR ICAM1 CCL5 ALB
22 allergic asthma 29.0 TSLP RNASE3 IL5 IL13 CCL5 CCL11
23 bronchiolitis 29.0 RNASE3 IL5 IL13 CXCL8 CCL5 CCL11
24 esophagitis 28.9 TSLP IL5 IL13 CXCL8 CCL11
25 lung disease 28.8 RNASE3 IL5 IL13 CXCL8 CCL5
26 allergic hypersensitivity disease 28.7 TSLP RNASE3 IL5 IL13 CCL5 CCL11
27 skin disease 28.5 RNASE3 IL5 IL13 ICAM1 CXCL8 CCL11
28 dermatitis, atopic 28.3 TSLP RNASE3 IL5 IL13 ICAM1 CXCL8
29 proteasome-associated autoinflammatory syndrome 1 28.3 SELP RNASE3 IL5 IL1R1 IL13 ICAM1
30 respiratory allergy 27.5 TSLP RNASE3 IL5 IL33 IL13 CCL11
31 allergic conjunctivitis 27.4 RNASE3 IL5 IL33 IL13 ICAM1 CXCL8
32 conjunctivitis 27.4 RNASE3 IL5 IL33 IL13 ICAM1 CXCL8
33 nasal cavity disease 27.1 TSLP RNASE3 IL5 IL33 IL13 ICAM1
34 asthma 26.9 TSLP SELP RNASE3 LPO IL5 IL1R1
35 malaria 26.8 SELP IL5 IL33 IL13 ICAM1 CXCL8
36 bronchial disease 26.2 TSLP RNASE3 POSTN IL5 IL33 IL13
37 upper respiratory tract disease 25.9 TSLP TAS2R38 RNASE3 IL5 IL33 IL13
38 nasopharyngitis 11.6
39 eosinophilic granulomatosis with polyangiitis 11.6
40 otosalpingitis 11.3
41 tonsillitis 11.3
42 pertussis 11.3
43 young syndrome 11.2
44 ciliary dyskinesia, primary, 22 11.2
45 erythema infectiosum 11.0
46 mda5 deficiency 11.0
47 papillary conjunctivitis 10.7 CXCL8 CCL11
48 chloramine t respiratory allergy 10.6 RNASE3 ALB
49 heterophyiasis 10.6 ICAM1 ALB
50 st. louis encephalitis 10.5 RNASE3 IFNA2

Graphical network of the top 20 diseases related to Common Cold:



Diseases related to Common Cold

Symptoms & Phenotypes for Common Cold

UMLS symptoms related to Common Cold:


fever, pruritus, tinnitus, snoring, rhinorrhea, sore throat, coughing, vertigo/dizziness, equilibration disorder, catarrh

MGI Mouse Phenotypes related to Common Cold:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.9 CCL11 CCL5 ICAM1 IL13 IL1R1 IL33
2 digestive/alimentary MP:0005381 9.8 ALB ICAM1 IL13 IL33 IL5 LDLR
3 immune system MP:0005387 9.7 CCL11 CCL5 ICAM1 IL13 IL1R1 IL33
4 respiratory system MP:0005388 9.17 CCL11 IL13 IL1R1 IL33 IL5 SELP

Drugs & Therapeutics for Common Cold

PubMed Health treatment related to Common Cold: 63

Because there are so many different cold viruses, there is currently no medicine that can fight all cold viruses and shorten the length of colds. But various medications can relieve some of the symptoms a little. These include painkillers like ibuprofen and acetaminophen (paracetamol), as well as decongestant (anti-swelling) nasal sprays for temporary use. Antibiotics are usually not effective against colds and, because of their possible side effects, should only be used if there are complications. Products that contain zinc, vitamin C, or echinacea extracts are also commonly recommended for the treatment of colds. It's not currently possible to reliably evaluate the advantages and disadvantages of these herbal products because there has been little research in this area, and the studies that have been done have produced contradictory results. Herbal products like extracts taken from Pelargonium (umckaloabo), primrose, thyme, eucalyptus and ivy may possibly be able to relieve a cough somewhat.

Drugs for Common Cold (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 391)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cefditoren Approved, Investigational Phase 4 104145-95-1, 117467-28-4 9870843 9571074
2
Capsaicin Approved Phase 4 404-86-4 1548943
3
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
4
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
5
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
6
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
7
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
8
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
9
Caffeine Approved Phase 4 58-08-2 2519
10
Ipratropium Approved, Experimental Phase 4 60205-81-4, 22254-24-6 657309 43232
11
Chlorpheniramine Approved Phase 4 132-22-9, 113-92-8 2725
12
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
13
Budesonide Approved Phase 4 51333-22-3 63006 5281004
14
Azithromycin Approved Phase 4 83905-01-5 447043 55185
15
Almotriptan Approved, Investigational Phase 4 154323-57-6, 181183-52-8 123606
16
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
17
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
18
Racepinephrine Approved Phase 4 329-65-7 838
19
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
20
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
21
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
22
Phenoxyethanol Approved Phase 4 122-99-6 31236
23
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
24
Prazosin Approved Phase 4 19216-56-9 4893
25
Acetaminophen Approved Phase 4 103-90-2 1983
26
Ibuprofen Approved Phase 4 15687-27-1 3672
27
Sodium citrate Approved, Investigational Phase 4 68-04-2
28
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
29
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
30
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
31
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
32
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
33
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
34
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
35
Polyestradiol phosphate Approved Phase 4 28014-46-2
36
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
37
Montelukast Approved Phase 4 158966-92-8 5281040
38
mometasone furoate Approved, Investigational, Vet_approved Phase 4 83919-23-7
39
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
40
Dextromethorphan Approved Phase 4 125-71-3 5360696 5362449
41
Clarithromycin Approved Phase 4 81103-11-9 84029
42
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 54670067 5785
43
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 6221 5280795
44
Ergocalciferol Approved, Nutraceutical Phase 4 50-14-6 5280793
45
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
46
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 22737-96-8, 11103-57-4, 68-26-8 9904001 445354
47
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
48
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
49
Maleic acid Experimental, Investigational Phase 4 110-17-8, 110-16-7 444972
50
BCG vaccine Investigational Phase 4

Interventional clinical trials:

(show top 50) (show all 499)
# Name Status NCT ID Phase Drugs
1 Clinical Relevance of Middle Meatal Bacteriology During Acute Respiratory Infection in Children - Randomised, Double-Blinded Clinical Study Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
2 Randomized,Double-blind, Placebo Controlled Clinical Trial to Evaluate the Efficacy of the Phytotherapic Compound "Bromelin" on Acute Irritative Cough Unknown status NCT01356693 Phase 4 Bromelin;Placebo
3 A Comparison of Cefditoren Pivoxil 10 mg/kg/Day and Cefditoren Pivoxil 20 mg/kg/Day in Treatment of Childhood With Acute Rhinosinusitis Unknown status NCT01553006 Phase 4 cefditoren pivoxil
4 Double-blind, Randomized, Placebo-controlled Clinical Study Investigating Efficacy and Safety of Arbidol (Umifenovir) in Treatment and Prophylaxis of Influenza and Common Cold. Unknown status NCT01651663 Phase 4 Arbidol (Umifenovir);Arbidol (Umifenovir)
5 The Adjunctive Use of a Dexamethasone-Sinufoam Mixture on Endoscopic Sinus Surgery Outcomes: A Randomized, Double-Blind, Placebo-controlled Trial Unknown status NCT01024075 Phase 4 Dexamethasone;Saline
6 The Evaluation of Singulair for the Treatment of Non-Allergic Rhinitis Eosinophil Syndrome (NARES) Unknown status NCT00406094 Phase 4 montelukast;placebo
7 Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis Unknown status NCT02288156 Phase 4 Capsaicin;placebo
8 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery: a 9-month Randomized, Open-label, Controlled Study Unknown status NCT02110654 Phase 4 Montelukast;mometasone furoate nasal spray
9 A Double Blind Randomised Placebo Controlled Trial of Montelukast in the Treatment of Acute Persistent Cough in Young People and Adults in Primary Care Unknown status NCT01279668 Phase 4 Montelukast;Placebo
10 Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children Unknown status NCT00494624 Phase 4 prednisolone
11 PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough Completed NCT02981147 Phase 4 Phytus (Cisti, Thyme and Ivy Leaves)
12 The HVSI STUDY: High Volume Saline Irrigation in the Post-operative Management of Chronic Rhinosinusitis: A Multicenter Randomized Single-Blind Controlled Trial Completed NCT01575223 Phase 4
13 Effects of a Common Cold Treatment on Cognitive Function Completed NCT01466348 Phase 4 Paracetamol and Caffeine;Paracetamol
14 A Phase IV Safety Trial in Pediatric Patients (Ages 2-5) With Rhinorrhea Associated With a Common Cold or Allergy Completed NCT02238210 Phase 4 Atrovent®
15 Efficacy and Safety of Iota-Carrageenan Nasal Spray 1.2 g/l (0.12 Percent) (Bisolviral) Versus Placebo Nasal Spray in the Early Treatment of Common Cold Completed NCT01944631 Phase 4
16 Double-blind, Randomized, Placebo-controlled, Single Dose, Parallel Group Study Evaluating Efficacy and Safety of 1000 mg Acetylsalicylic Acid and 1000 mg Paracetamol in Adult Patients With Sore Throat Associated With a Common Cold Completed NCT01465009 Phase 4 Acetylsalicylic acid (Aspirin, BAYE4465);Paracetamol;Placebo
17 A Two-arm, Multicenter, Randomized, Double-blind, Single Dose Placebo-controlled Parallel Groups Study Evaluating Efficacy and Tolerability of 800 mg Acetylsalicylic Acid (Aspirina® C) in Adult Patients With a Common Cold During a Two Hour in Patient Phase; and a Follow-up Period of Five Days of Home Treatment as Required Completed NCT01033526 Phase 4 Aspirin (Acetylsalicylic acid, BAYE4465);Placebo
18 The Use of Antibiotic Sinonasal Rinse After Sinus Surgery: A Randomized Double-Blind Control Trial Completed NCT02218307 Phase 4 Mupirocin;Placebo
19 Randomised Double Blind Placebo Controlled Multicenter Study for Evaluation of Clinical Efficacy and Safety of Ingavirin 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults. Completed NCT03154515 Phase 4 Ingavirin;Placebo
20 Safety and Efficacy of Long-term Treatment With Echinaforce® Over 4 Months Completed NCT01021995 Phase 4 echinacea;placebo
21 A Double-Blind, Randomised, Placebo-Controlled, Parallelgroup, Single-Dose Study to Evaluate Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza Over a 4 Hour Period Completed NCT02246166 Phase 4 Test tablet
22 Evaluation of Histamine, CGRP and VIP as Biological Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers in Response to "Sinus" Symptoms Completed NCT00208065 Phase 4 almotriptan or pseudoephedrine
23 Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis - a Randomized, Double Blind, Placebo Controlled Trial Completed NCT03086070 Phase 4 Omeprazole 20mg;Placebo oral capsule
24 A Community Pharmacy Based Investigation in the Self-Medication Area Efficacy and Safety of Sinutab and Pseudoephedrine on Subjects With Nasal Congestion Accompanied by Headache in the Setting of a Common Cold Completed NCT00378144 Phase 4 Pseudoephedrine/Paracetamol
25 Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis. A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase IV Study (Sinusitis Study) Completed NCT02296814 Phase 4 Sinusitis Hevert SL Tablet;Placebo for Sinusitis Hevert SL Tablet
26 Systemic Corticosteroids in the Perioperative Management of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Completed NCT02119273 Phase 4 Prednisone;Placebo
27 A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies Completed NCT01332578 Phase 4 Paracetamol;Phenylephrine;Ascorbic Acid
28 Efficacy and Tolerability of Systemic Methylprednisolone in Children and Adolescents With Chronic Rhinosinusitis Completed NCT01205984 Phase 4 methylprednisolone
29 Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis Completed NCT00396162 Phase 4 probiotic containing L.rhamnosus R0011 strain
30 Randomized Clinical Trial to Evaluate Guidelines for Acute Rhinosinusitis (Phase IV Study) Completed NCT00377403 Phase 4 Acetaminophen;Amoxicillin;Dextromethorphan hydrobromide with guaifenesin;Guaifenesin;Pseudoephedrine Sustained Action;Saline spray (0.65%)
31 A Prospective, Multi-Center, Randomized, Controlled, Subject-Blinded Study to Evaluate the Safety and Effectiveness of AdvaCoat Sinus Gel Following Endoscopic Ethmoid Sinus Surgery Completed NCT00554190 Phase 4
32 A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Mucinex D as Adjunct Therapy to Antibiotic Treatment of Acute Respiratory Infection Completed NCT00441246 Phase 4 Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets)
33 Randomized, Single Blind, Multicenter Study to Evaluate the Efficacy and Tolerability of Syr. Grintuss Pediatric and Syr. Mucolit in Cough Due to Upper Respiratory Tract Infection in Children Completed NCT01968434 Phase 4 carbocisteine cough syrup
34 Azithromycin as add-on Therapy in Patients Failing Medical and Surgical Treatment for Chronic Rhinosinusitis: a Double-blind, Randomized, Placebo-controlled Trial Completed NCT02307825 Phase 4 Azithromycin;Placebo
35 A Proof Of Concept Study to Investigate the Clinical, Histological And Molecular Predictors of Response to Oral and Intranasal Corticosteroid in Nasal Polyposis Completed NCT00788749 Phase 4 Prednisolone;Placebo
36 Prevention of RSV Infections in Bone Marrow Transplant Recipients Completed NCT00001903 Phase 4 RSV Polyclonal Immunoglobulin
37 Spine Patient Outcomes Research Trial (SPORT): A Multicenter Trial for Spinal Stenosis (SpS) Completed NCT00000411 Phase 4
38 The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis Completed NCT02696850 Phase 4 Budesonide;Saline alone
39 Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial Completed NCT01919411 Phase 4 Amoxicillin-Potassium Clavulanate;Placebo
40 Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies in the Non-complicated Acute Respiratory Tract Infections in General Practice Completed NCT01363531 Phase 4
41 Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections Completed NCT01728090 Phase 4
42 The Role of Nonspecific Immune Response of the Airway Mucosa in Children With Chronic Rhinosinusitis and Asthma Completed NCT03011632 Phase 4 Mometasone Nasal;placebo mometasone
43 A Randomized Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms Completed NCT00318006 Phase 4
44 Comparison of Topical Vasoconstriction in Endoscopic Sinus Surgery: Cocaine Versus Adrenaline Completed NCT01706952 Phase 4 Cocaine;Adrenaline
45 Clinical Trial for the Assessment of Delayed Antibiotic Treatment in the Non-complicated Acute Respiratory Tract Infections in Pediatric (Study DAP-Pediatrics) Completed NCT01800747 Phase 4
46 A Randomized Cohort Trial Evaluating Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis Completed NCT01825408 Phase 4 Doxycycline;Azithromycin;Augmentin
47 Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children. A Prospective, Randomised, Clinical Trial. Completed NCT01694108 Phase 4
48 Total Intravenous Versus Inhaled Anesthesia in Endoscopic Sinus Surgery for High-Grade Paranasal Disease Completed NCT02578862 Phase 4 Propofol;Sevoflurane
49 Medicated Punctured-Glove-Finger Spacer Study Completed NCT01420471 Phase 4 Triamcinolone
50 Spine Patient Outcomes Research Trial (SPORT): A Multicenter Randomized Trial for Intervertebral Disc Herniation (IDH) Completed NCT00000410 Phase 4

Search NIH Clinical Center for Common Cold

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Amoxicillin
Ascorbic Acid
Ascorbic Acid Powder
Azithromycin
Beclomethasone dipropionate
Brompheniramine
Budesonide
Camphor
Cefdinir
Cefixime
Cefotaxime
Ceftriaxone
Chlorcyclizine
Clemastine
Dexchlorpheniramine maleate
Diclofenac
Doxylamine
Echinacea Preparation
Fluticasone furoate
Fluticasone propionate
Guaifenesin
Hyoscyamine
Levofloxacin
Mepyramine
Mometasone
Pheniramine
Phenylpropanolamine
Phenylpropanolamine Hydrochloride
Pseudoephedrine
Pseudoephedrine Hydrochloride
Pseudoephedrine sulfate
Sodium Ascorbate
Sulbactam
Zinc
Zinc Acetate
zinc chloride
Zinc Gluconate
Zinc Sulfate
ZINC SULFATE PWDR

Cochrane evidence based reviews: common cold

Genetic Tests for Common Cold

Anatomical Context for Common Cold

MalaCards organs/tissues related to Common Cold:

41
Testes, Eye, Lung, Bone, T Cells, Skin, Heart

Publications for Common Cold

Articles related to Common Cold:

(show top 50) (show all 3419)
# Title Authors PMID Year
1
Human Rhinovirus Inhibits Macrophage Phagocytosis of Bacteria in Chronic Obstructive Pulmonary Disease. More Than a Common Cold. 38 17
30571921 2019
2
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR). 38 17
31094461 2019
3
The Spy Who Came In with a Cold. 17
30650318 2019
4
Cigarette smoke extract enhances rhinovirus-induced toll-like receptor 3 expression and interleukin-8 secretion in A549 cells. 9 38
19769802 2009
5
Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21. 9 38
14734451 2004
6
The common cold at the turn of the millennium. 9 38
11068660 2000
7
Experimental rhinovirus 16 infection increases intercellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment. 9 38
10848925 2000
8
Experimental common cold increases mucosal output of eotaxin in atopic individuals. 9 38
10604558 1999
9
Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds. 9 38
10836321 1999
10
Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. 9 38
9564459 1998
11
Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. 9 38
9105080 1997
12
Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. 9 38
7734976 1995
13
Analytical methods for the determination of paracetamol, pseudoephedrine and brompheniramine in Comtrex tablets. 38
31384825 2019
14
Extraction-free spectrophotometric assay of the antitussive drug pentoxyverine citrate using sulfonephthalein dyes. 38
31176152 2019
15
Long-term aquaria study suggests species-specific responses of two cold-water corals to macro-and microplastics exposure. 38
31323615 2019
16
Chronic rhino-sinusitis treatment in children with cystic fibrosis: A cross-sectional survey of pediatric pulmonologists and otolaryngologists. 38
31195306 2019
17
Common cold in Team Finland during 2018 Winter Olympic Games (PyeongChang): epidemiology, diagnosis including molecular point-of-care testing (POCT) and treatment. 38
31142472 2019
18
Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial. 38
31400107 2019
19
Comparison of serum eosinophil-derived neurotoxin levels between wheezing and non-wheezing groups in children with respiratory tract infection. 38
31298976 2019
20
A multicenter study on the efficacy and safety of So-Cheong-Ryong-Tang for perennial allergic rhinitis. 38
31331582 2019
21
Knowledge of antibiotics and antimicrobial resistance amongst final year dental students of Polish medical schools-A cross-sectional study. 38
30729642 2019
22
Meta-analysis on vitamin C and the common cold in children may be misleading. 38
31377890 2019
23
The use of a poster to reduce expectations to receive antibiotics for a common cold. 38
31102079 2019
24
Laypersons' perception of common cold and influenza prevention-a qualitative study in Austria, Belgium and Croatia. 38
31431093 2019
25
Minimally invasive resection of a giant left atrial myxoma: a case report. 38
31366281 2019
26
A coarse-grained model of the expansion of the human rhinovirus 2 capsid reveals insights in genome release. 38
31409237 2019
27
Identification of plasticity and interactions of a highly conserved motif within a picornavirus capsid precursor required for virus infectivity. 38
31409836 2019
28
Reduning injection ameliorates paraquat-induced acute lung injury by regulating AMPK/MAPK/NF-κB signaling. 38
30861187 2019
29
Ex-post moral hazard in the health insurance market: empirical evidence from German data. 38
31407102 2019
30
Green Liquid Chromatographic Methods with Ultraviolet and Tandem Mass Spectrometry Detection: An Application to Ternary Mixture of Paracetamol, Pseudoephedrine, and Cetirizine in Capsules. 38
31284898 2019
31
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis. 38
30991818 2019
32
Rhinovirus replication and innate immunity in highly differentiated human airway epithelial cells. 38
31299975 2019
33
Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: A randomized placebo-controlled trial. 38
31302340 2019
34
Tuina for children with upper respiratory tract infections: A protocol for a systematic review. 38
31305472 2019
35
HIV/AIDS and intersectional stigmas: Examining stigma related behaviours among medical students during service delivery. 38
31296120 2019
36
The Role of Zinc in Antiviral Immunity. 38
31305906 2019
37
Viral ecosystem: An epidemiological hypothesis. 38
31206234 2019
38
Determination of genotoxic and antigenotoxic effects of wild-grown Reishi mushroom (Ganoderma lucidum) using the hen's egg test for analysis of micronucleus induction. 38
31282205 2019
39
Year-Long Rhinovirus Infection is Influenced by Atmospheric Conditions, Outdoor Air Virus Presence, and Immune System-Related Genetic Polymorphisms. 38
31350695 2019
40
When more is less: What explains the overuse of health care services in China? 38
31048192 2019
41
A Multicenter, Randomized, Placebo-Controlled Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold. 38
31274197 2019
42
Correction to: Safety and Efficacy of 0.5% Carbomer 980 Gel for Treatment of Symptoms of Common Cold: Results of 2 Randomized Trials. 38
31327147 2019
43
Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs. 38
30672366 2019
44
Human bocaviruses and paediatric infections. 38
30948251 2019
45
Non-interventional observational study broadens positive benefit-risk assessment of an immunomodulating herbal remedy in the common cold. 38
31074674 2019
46
Correction to: "With fever it's the real flu I would say": laypersons' perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia. 38
31242872 2019
47
Protocol for a randomised, single-blind, two-arm, parallel-group controlled trial of the efficacy of rhinothermy delivered by nasal high flow therapy in the treatment of the common cold. 38
31221888 2019
48
Safety and Efficacy of 0.5% Carbomer 980 Gel for Treatment of Symptoms of Common Cold: Results of 2 Randomized Trials. 38
31004286 2019
49
Smart Spectral Processing of Data for the estimation of Commonly Used Over-the-counter (OTC) Co-formulated drug; Pseudoephedrine hydrochloride and Ibuprofen. 38
31323498 2019
50
Antibiotics use, knowledge and practices on antibiotic resistance among breastfeeding mothers in Kaduna state (Nigeria). 38
31256979 2019

Variations for Common Cold

Expression for Common Cold

Search GEO for disease gene expression data for Common Cold.

Pathways for Common Cold

Pathways related to Common Cold according to GeneCards Suite gene sharing:

(show all 28)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.94 RNASE3 IL5 IL33 IL1R1 IL13 IFNA2
2
Show member pathways
13.55 TSLP IL5 IL33 IL1R1 IL13 IFNA2
3
Show member pathways
13.44 IL5 IL1R1 IL13 IFNA2 ICAM1 CXCL8
4
Show member pathways
13.2 IL5 IL33 IL1R1 IL13 IFNA2 ICAM1
5
Show member pathways
12.66 RNASE3 IL5 IL13 IFNA2 ICOSLG ICAM1
6
Show member pathways
12.3 TSLP IL5 IL13 IFNA2
7
Show member pathways
12.23 ICAM1 CXCL8 CCL5 CCL11
8
Show member pathways